Retroscreen Buys Proteomics Firm Activiomics for $6.7M | GenomeWeb

NEW YORK (GenomeWeb News) – Retroscreen Virology Group today announced it has acquired proteomics firm Activiomics for up to £4.0 million ($6.7 million).

In connection with the deal, Retroscreen is issuing up to £4.0 million of new ordinary shares of £.05 each of its stock, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.